N S Dhalla Selected Research

N S Dhalla Research Topics

Disease

10	Heart Failure 08/2003 - 01/2000
5	Cardiomyopathies (Cardiomyopathy) 08/2003 - 01/2000
5	Ischemia 11/2001 - 04/2000
3	Cardiomegaly (Heart Hypertrophy) 04/2006 - 10/2000
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2001 - 04/2000
3	Myocardial Infarction 04/2001 - 01/2000
2	Heart Diseases (Heart Disease) 12/2021 - 04/2001
2	Atherosclerosis 01/2009 - 06/2000
1	Body Weight (Weight, Body) 01/2013
1	Inflammation (Inflammations) 01/2009
1	Hypertrophy 04/2006
1	Cicatrix (Scar) 01/2004
1	Infarction (Infarctions) 01/2004
1	Hypoxia (Hypoxemia) 11/2001
1	Hyperplasia 06/2001
1	Reperfusion Injury 08/2000
1	Diabetic Cardiomyopathies 06/2000
1	Hypertension (High Blood Pressure) 06/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2000
1	Hypothermia 04/2000
1	Coronary Occlusion 01/2000
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2000

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2000
5	phospholambanIBA 01/2004 - 04/2000
4	Messenger RNA (mRNA)IBA 04/2006 - 01/2000
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2004 - 04/2000
4	Adenosine Triphosphatases (ATPase)IBA 01/2004 - 01/2000
4	CalsequestrinIBA 11/2001 - 04/2000
3	CatecholaminesIBA 05/2003 - 11/2000
3	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2000 - 04/2000
3	AntioxidantsIBA 08/2000 - 01/2000
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 11/2001
2	IsoenzymesIBA 04/2006 - 03/2001
2	Losartan (Cozaar)FDA LinkGeneric 04/2006 - 09/2000
2	Type C PhospholipasesIBA 04/2006 - 03/2001
2	salicylhydroxamic acid (SHAM)IBA 01/2004 - 03/2001
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2003 - 07/2003
2	sarpogrelateIBA 09/2001 - 06/2001
2	Serotonin (5 Hydroxytryptamine)IBA 09/2001 - 06/2001
2	EnzymesIBA 01/2001 - 04/2000
2	Propranolol (Inderal)FDA LinkGeneric 10/2000 - 04/2000
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2000 - 06/2000
2	Vitamin E FDA LinkGeneric 08/2000 - 01/2000
1	Taurine FDA Link 01/2013
1	CholesterolIBA 01/2013
1	Cysteine (L-Cysteine)FDA Link 01/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	Streptozocin (Streptozotocin)FDA Link 01/2013
1	Lipoxygenase InhibitorsIBA 01/2009
1	Probucol (Lorelco)FDA Link 01/2009
1	lysophosphatidic acidIBA 01/2009
1	Sterol O-AcyltransferaseIBA 01/2009
1	LipidsIBA 01/2009
1	ProstaglandinsIBA 01/2009
1	Antihypertensive Agents (Antihypertensives)IBA 01/2009
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2009
1	cyclopentenoneIBA 01/2009
1	Phospholipase C betaIBA 04/2006
1	Phospholipase C gammaIBA 04/2006
1	Ventricular MyosinsIBA 01/2004
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2004
1	Amlodipine (Norvasc)FDA LinkGeneric 08/2003
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2003
1	Digoxin (Digitek)FDA LinkGeneric 08/2003
1	DiureticsIBA 08/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2003
1	ColforsinIBA 07/2003
1	Guanylyl ImidodiphosphateIBA 07/2003
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2003
1	imidaprilIBA 07/2003
1	adrenolutinIBA 05/2003
1	Oxygen (Dioxygen)IBA 11/2001
1	Phosphatidic Acids (Phosphatidic Acid)IBA 03/2001
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2001
1	Nuclear Proteins (Protein, Nuclear)IBA 11/2000
1	Verapamil (Calan)FDA LinkGeneric 10/2000
1	Calcium Channels (Calcium Channel)IBA 10/2000
1	Captopril (Capoten)FDA LinkGeneric 09/2000
1	Glutathione PeroxidaseIBA 08/2000
1	CatalaseIBA 08/2000
1	Superoxide DismutaseIBA 08/2000
1	Glycerophospholipids (Phosphoglycerides)IBA 06/2000
1	Atenolol (Tenormin)FDA LinkGeneric 04/2000
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 03/2000
1	E 25 (E-25)IBA 01/2000
1	Polyvinyl Chloride (PVC)IBA 01/2000

Therapy/Procedure

3	Ligation 01/2004 - 01/2000
2	Therapeutics 01/2009 - 06/2000
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2001